Clinical Trials in Detroit

Showing 17781-17800 of 19,719 trials

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

NCT00016185

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one drug may kill more tumor cells. PURPOSE: Phase I trial to study the effectiveness of combining flavopiridol and docetaxel in treating patients who have advanced solid tumors.

Unspecified Adult Solid Tumor, Protocol Specific

Barbara Ann Karmanos Cancer InstituteStarted Mar 2001

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

NCT00002907

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of bryostatin 1 in treating patients with relapsed multiple myeloma.

Multiple Myeloma and Plasma Cell Neoplasm

Barbara Ann Karmanos Cancer InstituteStarted Jan 1997

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

NCT00243048

RATIONALE: Eating a diet high in soy foods may slow the progression of some types of cancer. Isoflavones are compounds found in soy food that may slow the growth of prostate cancer cells and prevent further development of prostate cancer. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving isoflavones together with radiation therapy may be an effective treatment for prostate cancer. PURPOSE: This randomized phase II trial is studying the side effects and how well giving isoflavones together with radiation therapy works in treating patients with localized prostate cancer.

Prostate Cancer

Barbara Ann Karmanos Cancer Institute70 participantsStarted May 2002

Detroit, Michigan, United States

COMPLETEDPhase 2< 1 mile

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

NCT00004024

RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. Combining different types of biological therapies may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of biological therapy following surgery and radiation therapy in treating patients who have primary or recurrent astrocytoma or oligodendroglioma.

Brain and Central Nervous System Tumors

Barbara Ann Karmanos Cancer Institute60 participantsStarted Jun 1997

Detroit, Michigan, United States

Flavopiridol and Docetaxel in Treating Patients With Advanced Solid Tumors

Bryostatin 1 in Treating Patients With Relapsed Multiple Myeloma

Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate Cancer

Biological Therapy Following Surgery and Radiation Therapy in Treating Patients With Primary or Recurrent Astrocytoma or Oligodendroglioma

Find Trials by Condition in Detroit

Efficacy and Safety Study of CC-5013 Monotherapy in Subjects With Myelodysplastic Syndromes

MGCD290 and Fluconazole Versus Fluconazole Alone for the Treatment of Moderate to Severe Vulvovaginal Candidiasis

Secondary Prevention of Small Subcortical Strokes Trial

Iloprost Power Disc-15 in Pulmonary Arterial Hypertension

Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women

A Study of Safety and Effectiveness of Ustekinumab in Patients With Moderate to Severe Active Crohn's Disease Who Have Been Previously Treated With Anti-TNF Therapy

Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

LOTRONEX® in Severe Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)

Study to Assess Droxidopa in the Treatment of Freezing Of Gait Symptoms in Patients With Parkinson's Disease

Carboplatin and Irinotecan in Treating Children With Refractory Solid Tumors

The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc-15 Setting

Safety and Efficacy of HO/03/03 10μg in the Treatment of Plantar Neuropathic Diabetic Foot Ulcers

Erlotinib in Treating Patients With Advanced Non-Small Cell Lung Cancer

Potential of Florbetapir F 18 PET to Inform Clinical Diagnosis and Management of Patients With Progressive Cognitive Decline

Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery

Insulins Glargine and gluLisine strAtegy Versus Premixed Insulin strAteGy: a cOmparative Study